Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 7
2003 7
2004 8
2005 10
2006 11
2007 8
2008 5
2009 13
2010 20
2011 20
2012 13
2013 12
2014 8
2015 19
2016 12
2017 4
2018 9
2019 15
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Results by year
Filters applied: . Clear all
Page 1
Brain tumour cells interconnect to a functional and resistant network.
Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M, Huang L, Ratliff M, Karimian Jazi K, Kurz FT, Schmenger T, Lemke D, Gömmel M, Pauli M, Liao Y, Häring P, Pusch S, Herl V, Steinhäuser C, Krunic D, Jarahian M, Miletic H, Berghoff AS, Griesbeck O, Kalamakis G, Garaschuk O, Preusser M, Weiss S, Liu H, Heiland S, Platten M, Huber PE, Kuner T, von Deimling A, Wick W, Winkler F. Osswald M, et al. Among authors: huber pe. Nature. 2015 Dec 3;528(7580):93-8. doi: 10.1038/nature16071. Epub 2015 Nov 4. Nature. 2015. PMID: 26536111
Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis.
Bickelhaupt S, Erbel C, Timke C, Wirkner U, Dadrich M, Flechsig P, Tietz A, Pföhler J, Gross W, Peschke P, Hoeltgen L, Katus HA, Gröne HJ, Nicolay NH, Saffrich R, Debus J, Sternlicht MD, Seeley TW, Lipson KE, Huber PE. Bickelhaupt S, et al. Among authors: huber pe. J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw339. J Natl Cancer Inst. 2017. PMID: 28376190
Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.
Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L, Klapproth K, Schäkel K, Garbi N, Jäger D, Weitz J, Schmitz-Winnenthal H, Hämmerling GJ, Beckhove P. Klug F, et al. Among authors: huber pe. Cancer Cell. 2013 Nov 11;24(5):589-602. doi: 10.1016/j.ccr.2013.09.014. Epub 2013 Oct 24. Cancer Cell. 2013. PMID: 24209604 Free article.
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.
Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. Xie N, et al. Among authors: huber pe. Signal Transduct Target Ther. 2020 Oct 7;5(1):227. doi: 10.1038/s41392-020-00311-7. Signal Transduct Target Ther. 2020. PMID: 33028824 Free PMC article. Review.
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
Bozorgmehr F, Hommertgen A, Krisam J, Lasitschka F, Kuon J, Maenz M, Huber PE, König L, Kieser M, Debus J, Thomas M, Rieken S. Bozorgmehr F, et al. Among authors: huber pe. BMC Cancer. 2019 Nov 8;19(1):1074. doi: 10.1186/s12885-019-6205-0. BMC Cancer. 2019. PMID: 31703637 Free PMC article. Clinical Trial.
[Normal tissue: radiosensitivity, toxicity, consequences for planning].
Rühle A, Huber PE. Rühle A, et al. Among authors: huber pe. Radiologe. 2018 Aug;58(8):746-753. doi: 10.1007/s00117-018-0430-4. Radiologe. 2018. PMID: 29992402 Review. German.
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M, Loktev A, Wefers AK, Altmann A, Paech D, Adeberg S, Windisch P, Hielscher T, Flechsig P, Floca R, Leitz D, Schuster JP, Huber PE, Debus J, von Deimling A, Lindner T, Haberkorn U. Röhrich M, et al. Among authors: huber pe. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580. doi: 10.1007/s00259-019-04444-y. Epub 2019 Aug 6. Eur J Nucl Med Mol Imaging. 2019. PMID: 31388723
The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy-induced toxicity.
Rühle A, Huber PE, Saffrich R, Lopez Perez R, Nicolay NH. Rühle A, et al. Among authors: huber pe. Int J Cancer. 2018 Dec 1;143(11):2628-2639. doi: 10.1002/ijc.31619. Epub 2018 Aug 7. Int J Cancer. 2018. PMID: 29931767 Free article. Review.
The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.
Rühle A, Lopez Perez R, Zou B, Grosu AL, Huber PE, Nicolay NH. Rühle A, et al. Among authors: huber pe. Stem Cell Rev Rep. 2019 Jun;15(3):356-373. doi: 10.1007/s12015-019-09886-3. Stem Cell Rev Rep. 2019. PMID: 30937640 Review.
Human mesenchymal stem cells are resistant to UV-B irradiation.
Lopez Perez R, Brauer J, Rühle A, Trinh T, Sisombath S, Wuchter P, Grosu AL, Debus J, Saffrich R, Huber PE, Nicolay NH. Lopez Perez R, et al. Among authors: huber pe. Sci Rep. 2019 Dec 27;9(1):20000. doi: 10.1038/s41598-019-56591-9. Sci Rep. 2019. PMID: 31882818 Free PMC article.
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback